Guiding the mission, scope, and directives of the San Diego Venture Group
SDVG’s Board of Directors is comprised of regional VCs, founders and CEOs. Each board member is responsible for helping coordinate at least one program per year. All are prominent members of the community.
Derek Barclay is a passionate entrepreneur who has been in the consumer finance industry for over 4 years. He was the co-founder and CEO of BounceBack Finance, a sales and marketing company that partnered with multiple consumer finance lenders. He successfully grew and led the company to a merger and acquisition with a growing medical fund out of Utah. Utilizing the knowledge gained through this experience, Derek co-found First Look Approval shortly after which had a focus on consulting with merchants on the variety of available consumer finance programs in today’s market. After working with over two dozen different financing programs, Derek saw a need for merchants to access multiple lenders through one universal process and streamlined system, which is why LoanHero was formed.
Jeffrey Belk is Managing Director of ICT168 Capital, LLC, focused on developing and guiding global growth opportunities in the Information and Communication Technology space. Formerly, Belk spent almost 14 years at Qualcomm Incorporated (from when the company was $200M in revenue to $7B+), where prior to his departure in early 2008, he was Qualcomm’s senior vice president of strategy and market development, focused on examining changes in the wireless ecosystem and formulating approaches to help accelerate the adoption of mobile devices, applications, and services.
1. I have launched 84 astronauts into space while working on the Space Shuttle program.
2. I am an ENTJ and high Influencer on the DISC survey.
3. I have run over 62 miles at once while climbing 12,000 feet on trails.
4. I am energized by helping others discover their calling.
5. I have always lived less than 20 miles from a beach.
Serial entrepreneur, award winning inventor (30+ patents apps), product designer (dozens of awards), marketer, and scientist (National Science Foundation grantee/principal investigator). Mark has 25+ yrs in semiconductor, wireless, healthcare, environmental, consumer/retail industries and has formation and founding 7 tech start-ups for which he has raised 17 rounds of VC financing (nearly $250M). Prior to co-founding Salveo, Mark founded ecoATM ($350M acq by Outerwall in ’13); was VP Mktg with Vativ (sold to Entropic); co-founded Staccato in 2002 as VP Mktg & Bus. Dev; co-founder and President/COO and director of BOPS, Inc (sold to Altera). Prior to this he helped form and fund Power Computing ($130M acq by Apple in ’96); Panorama Designs (acq by Motorola in ’96); and BlueSteel Networks (2000 acq by Broadcom for $110M). Mr. Bowles also spent six years at Motorola Semiconductor where he held various distribution management, sales and market development positions; he left Motorola in ’96 as VP MSPI of PowerPC Market Development.
Carin is the president and founder of Canale Communications Inc. In her role as president, Carin works closely with client teams, having provided senior level strategy to more than 125 life science companies of all shapes and sizes ranging from pre-series A financing to billion dollar public companies such as Amgen and Johnson & Johnson. Through her career in life science communications, she has advised a diverse range of companies including biotechnology, biopharmaceutical, medical device, diagnostics, research organizations and providers of enabling technologies.
In addition to client services, Carin is actively involved in the life science community and is a member of the board of directors for BIOCOM, Southern California’s life science trade association, and the San Diego Venture Group. A sought-after speaker, Carin frequently leads presentations and trainings on various communication topics for these organizations and others such as PRSA, the Biotechnology Industry Organization and California Healthcare Institute.
As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering. David received an M.B.A. from the Harvard Graduate School of Business Administration and graduated Summa Cum Laude with a B.S. in Biology from Princeton University.
Thomas A. Coll is a partner in the Cooley Business department and head of the Business & Technology Practice Group in the firm’s San Diego office, where he resides. Mr. Coll joined the firm in 1989, practicing in the San Francisco office until moving to San Diego as a founding member of that office in November 1991.
Mr. Coll’s practice covers a broad range of general corporate matters, including counseling public and privately-held companies regarding disclosure and reporting requirements, technology licensing, equity incentives, employee compensation and benefits and the formation of new businesses. Mr. Coll also represents clients in a broad range of transactional matters, including public offerings, public and private company mergers and acquisitions, corporate partnering and licensing transactions, spin-offs and venture capital financings. He is counsel to public and private companies in a broad range of industries, with a focus on the computer hardware and software, telecommunications, biotechnology and medical products industries.
From 2007-2016, Mr. Coll was named to the Best Lawyers in America list in the categories of Biotechnology Law, Corporate Law, Leveraged Buyouts and Private Equity Law, and Venture Capital Law. He was also named in the 2007-2012 and 2014 editions of Southern California Super Lawyers list in the category of Business/Corporate Law.
Michele has over 12 years’ experience in the insurance industry and has served as a member of Barney & Barney’s Executive Liability Practice since 2005. Michele has a background in finance and risk management and works directly with clients by providing strategic guidance and counsel in the areas of public company Directors & Officers liability.
Michele is a founding member of the Insurance Industry Charitable Foundation’s San Diego Chapter. She currently also holds a board position with the San Diego Venture Group. Michele currently serves as a committee chair with B&B GROW, a women’s initiative focused on attracting, retaining, educating and supporting the women of Barney & Barney.
Work with C-level executives to maximize their Human Capital investment. Present value of outsourcing HR Administration through a partnership with TriNet. Services include administration of F-500 benefits, payroll, HR best practices, liability management, government compliance, workers compensation, and HRIS technology. Manage all aspects of a complex sales process from business development to contract negotiation while collaborating with internal service team.
Dr. Stacey L. Davenport is the Founder and CEO of Davenport Executive Search as well as co-founder of DavenportMajor Executive Search. Her hands-on operational leadership in Life Sciences and Healthcare has been sought after by clients worldwide. Ms. Davenport brings a depth of clinical experience combined with a strong track record of executive search expertise which has made her a well respected public figure in the industry with numerous interviews in the Wall Street Journal, an interview on the NBC Evening News with Tom Brokaw and recent highlights in Forbes and Business Week, among many others.
She specializes exclusively in Life Sciences/Healthcare serving Fortune 500 global organizations as well as private equity and venture backed, emerging growth companies. Previously, she served as the Life Sciences and Board of Directors Practice Leader for AT Kearney Executive Search, the fifth largest retained, global executive search firm. Prior to her search career, she spent 10 yrs in interventional cardiology clinical practice in Dallas, Texas with the last 3 years leading the practice as Executive Director.
Business Lawyer at Procopio, 140-attorney law firm in San Diego and Menlo Park, CA (www.procopio.com). Venture capital, angel finance, governing, operating, buying, selling and merging growing technology & other businesses. Corporate & business transactions, including telecommunications, e-commerce, clean technology, energy, biotech, corporate governance, employment & independent contractor issues, intellectual property protection, competitive business practices, securities, business structuring & financing, contractual & political issues re telecom and independent power producers.
CPA focusing mostly on life science companies ranging from start-up to public companies. Co-lead KPMG San Diego’s life science practice and venture capital practice. I service companies ranging from emerging growth IPO companies to mature public companies.
Scott oversees Square 1’s banking practice in the Pacific Southwest. Scott was a cofounder of Square 1, and has nearly 20 years of financial services experience, with over 15 in the life sciences and technology venture banking industries. Scott previously served as vice president for Comerica Bank and Imperial Bank, where he concentrated on providing venture financing for early-stage life science and technology companies. Scott is an active member of several venture capital and life sciences industry associations, including the San Diego Venture Group and serves on the board of BIOCOM.
Scot Ginsburg has been solely focused on exclusively representing tenants and owner-users of space needs throughout his commercial real estate career. With over $2 Billion in transaction volume and 14,000,000 square feet of experience, Scot specializes in high-tech, life science, business service, research and development, and other growth-oriented industries. His commitment to provide the highest level of service is evidenced by his loyal clients whom he has repeatedly represented.
Scot’s passion for representing tenants exclusively comes from his personal experience as co-founder of a former high-tech company, where he found himself as the tenant on an uneven playing field with the landlords and their listing brokers.
Scot brings a wealth of experience ranging from lease acquisitions, lease renewals, lease restructures, build-to-suit developments, property acquisitions, and specialized tenant improvements designed for today’s demanding businesses.
My practice involves initial public offerings, public and private securities offerings, mergers and acqusitions and venture capital financings for Information Technology and Life Sciences companies.
I enjoy working with entrepreneurs and helping them to grow and finance their businesses. I also enjoy learning about new technologies, particularly in software, wireless, semiconductors, clean energy, medical devices and biotechnology.
I have served in both the law firm environment and as in-house counsel and a senior executive with a venture-backed internet company and a hedge fund.
Nationwide, Moss Adams and its affiliates provide insight and expertise integral to the success of organizations across the globe.A leader in assurance, tax, consulting, risk management, transaction, and wealth services, Moss Adams has a staff of over 1,700 that includes more than 220 partners. We focus on serving public, private, and not-for-profit enterprises across the nation through specialized industry and service teams.
Bruce Hansen brings three decades of experience building companies across the burgeoning big data analytics industry. Currently, Hansen is a board member at publicly-traded companies Verisk Analytics (NASDAQ: VRSK), Performant Financial Corporation (NASDAQ: PFMT) and MITEK Systems Inc. (NASDAQ: MITK), along with privately-held Zyme Solutions. He is also an active member of the National Association of Corporate Directors (NACD).
From 2002 to 2012, Hansen was co-founder, chairman and CEO at ID Analytics. He raised $45 million in venture financing and built ID Analytics from concept stage into a high-growth, profitable firm serving 280 enterprises and 5 million consumers. In 2012, Hansen orchestrated the sale of the company to LifeLock for approximately $200 million.
Prior to ID Analytics, Hansen was president at HNC Software Inc. (NASDAQ: HNCS), a $1 billion+ global provider of analytic software in financial services, telecom and healthcare. HNC was acquired by FICO in 2002. Prior, Hansen was CEO at CASA Inc., a privately-held advanced analytics company acquired by HNC. He has also held executive roles at CitiGroup, ADP, and JP Morgan Chase.
During the last 10 years I have managed businesses involving the fusion of hardware devices, software, and cloud subscription services.
I have led 3 startups to an exit, and stayed on to lead and integrate 2 of these businesses into publicly traded acquiring companies. My P&L ownership roles have ranged from early stage to $100M+ in revenue.
My passion is investing in great teams to deliver products and services which create new markets or disrupt existing ones. I enjoy customer engagement, mentoring, continuous learning, and driving strategic value. I am fortunate that I get to do these things daily supporting portfolio companies at FusionX Ventures.
Mike is an audit partner with Ernst & Young LLP and has nearly 20 years of experience in public accounting with a focus on serving publicly traded companies and private strategic growth market accounts. He has strong industry expertise in manufacturing, medical device and retail and consumer products. Mike has been involved in numerous initial and secondary public offerings and has participated in multiple acquisition audits and related SEC filings.
Mike has had many roles in serving the community and currently serves on both the Advisory Board for the School of Accountancy and the Advisory Board for the Entrepreneurial Management Center at San Diego State University.
http://www.sdvg.org/wp-content/uploads/2011/09/Michael-Howard.jpg250250adminhttp://www.sdvg.org/wp-content/uploads/2016/04/sdvg-logo.pngadmin2011-09-26 17:32:592016-07-18 20:44:02Michael Howard (Treasurer)
Cheryl Kessler is an expert in business valuations and forensic accounting specializing in valuation opinions for: marital dissolutions; gift and estate tax planning purposes; mergers & acquisitions; shareholder buyouts; and stock option plans. For over 20 years, Ms. Kessler has helped closely-held companies in many industries determine the value of their business. Ms. Kessler presents a credible, defensible and easy to understand analysis of financial and complex valuation issues in concise reports and/or via expert testimony. She prides herself on timely, thorough, and cost effective analysis. Ms. Kessler has the experience, knowledge and expertise to perform business valuations and income for support analysis for Family Law cases, and has served as a 730 neutral expert and has been qualified as an expert witness at trial in both California and Colorado.
Prior to Vantage Point Advisors, Inc., Ms. Kessler was a co-founder and CFO of a public company, Open Energy Corporation, a pioneer in building-integrated (BIPV) solar roofing products. As CFO, Ms. Kessler assisted with negotiations and legal documents to close on $20 million of convertible debentures. Ms. Kessler was in charge of writing and managing the annual Proxy filings; SB-2A registration statement filings; and 10K & 10Q filings.
I started Skyriver IT in 2009 with the goal of transforming the IT services industry. I recognized many of the issues with the IT service industry while working as a financial and operational executive in a mid-sized company and in other roles I held in the business world. I experienced first-hand the frustrations and challenges that businesses face dealing with IT and I saw an opportunity to create a solution.
I identified the key issues within the IT industry and drew on my diverse experience to create a solution. I believe that my company’s success directly correlates to the caliber of our staff. I have developed a strategic system for hiring and training the right people, a challenge that many businesses face when hiring internally. Customer service is key to the way we conduct business; I train my employees to be accessible and communicate clearly. I believe in cultivating a positive and friendly work environment that allows my company to function efficiently and effectively.
SOCI is developing the new standard in social media management. With its comprehensive enterprise tools platform, proprietary Content Recommendation Engine and Instant Insight scoring algorithms, SOCI is helping businesses and digital marketing firms achieve success in social media. Complete with a calendaring system, design center, conversation tracker, reporting capabilities and the content and insights that drive it all, the SOCI platform enables a highly efficiency, yet highly effective Do-It-Yourself and Do-It-For-Them solution. Look out Hootsuite… we’re growing up fast.
Wells Fargo’s Technology, Media, and Telecom (TMT) Group provides innovative financial solutions, a robust suite of banking products and services, and industry expertise to companies across their growth stages – from startups, to middle-market movers, to large corporates. To help our customers succeed globally our industry aligned relationship teams located across the U.S., Canada, Asia, and the UK, support companies in the following specializations: Technology, Business & Transaction Services, Media, Telecom, Fintech, and Clean Tech.
Candace Klein is Chief Strategy Officer for Dealstruck (dealstruck.com), an alternative Peer-to-Peer lending platform that provides loans and lines of credit to small business borrowers. Prior to Dealstruck, Candace co-authored the legislation that became the JOBS Act, then chaired the Crowdfund Intermediary Regulatory Advocates, the industry advocacy group for platforms and broker dealers affected by the JOBS Act. Candace was the founder and CEO of two companies: Bad Girl Ventures (bgv.bz) and SoMoLend (somolend.com). Bad Girl Ventures is a non-profit, micro-finance organization focused on educating and financing woman-owned startup companies. SoMoLend was a technology platform that connected business borrowers seeking loans of $35,000 or less with lenders looking to make a return on investment.
Cheston Larson serves as Chair of Latham’s San Diego Corporate Department and Emerging Companies Practice, and is Co-chair of the firm’s Life Sciences Industry Group. Cheston’s practice covers a broad range of general corporate matters, including counseling public and privately-held companies as well as representing venture capital and investment banking firms in private and public financing transactions.
Cheston advises clients on the formation of new businesses and their capital raising transactions, spanning the spectrum from angel and venture financings to IPOs, follow-on offerings, PIPEs and debt financing. He also regularly represents clients in mergers and acquisitions, corporate partnering transactions, licenses and strategic alliances. Cheston’s expertise also includes SEC disclosure and reporting requirements, Nasdaq and NYSE compliance and management compensation and equity incentive matters.
Cheston routinely counsels clients in the life sciences, software, telecommunications, cleantech and other technology industries.
Seasoned executive with track record of delivering innovative products and solutions into technically demanding markets. Strong communications and leadership skills for developing adaptable, high performance teams. Proven ability to initiate sales, drive product marketing, and develop channels. Clear understanding of board and investor motivations and needs. Core business approach: use data-driven decision-making to execute disruptive, first-mover attack against incumbents and into new markets.
Responsible for Qualcomm Ventures investment activities in North America. He currently manages and actively serves as a board observer for Qualcomm Ventures investments in A123 Systems, AMEC, InvenSense, Siimpel and Tela Innovations.
Crescent Ridge Partners is a venture fund that provides seed capital to early stage start-ups. We seek entrepreneurs developing disruptive technologies who have the passion, vision, and experience to build a great company. We take an active role in our investments, helping our companies succeed at the earliest stage by offering strategic advice, identifying early customers, and providing access to expansion capital. We welcome syndications and collaborations with other early stage investors, including angel groups, micro funds, and venture capital firms.
Bill, based in the San Diego office, has lead PricewaterhouseCoopers’ Southern California Pharma/Life Sciences practice. Prior to joining the San Diego office, Bill spent close to four years in Shanghai and led the China/Hong Kong Technology Practice. He brings over twenty-eight years of diversified experience providing accounting, business advisory and auditing services to life science and emerging-growth clients. Bill’s areas of expertise include mergers & acquisitions, capital transactions, initial and secondary public offerings, private placements and venture capital. Bill’s expertise and industry insights have been featured in local papers including the San Diego Union-Tribune, San Diego Business Journal, Philadelphia Inquirer and Philadelphia Business Journal, as well as the Wall Street Journal.
For over 28 years, Bill has worked closely with global as well as emerging-growth companies. He has served as audit partner on many of our publicly traded and private life sciences Southern California clients. He has extensive global coordination experience including the four years in China where he was the territory lead partner on multinational clients and led our China/Hong Kong Technology practice. Bill has also recently served as the global engagement partner for an advisory client (Fortune 600 medical instrumentation company), leading strategic initiatives such as acquisitions and transaction structuring, tax strategies, loyalty programs, and process improvement. He specializes in supporting companies with acquisitions, mergers, divestitures, initial public offerings (IPOs) and other capital market transactions including assisting with purchase price accounting, required financial reporting and disclosures, opening balance sheet valuations and audit planning to incorporate the changes to the business post-transaction into the consolidated audit.
A serial entrepreneur, through three VC backed technology companies. The largest, eAssist raised over $60M from top-tier VCs to support international expansion of an enterprise CRM solution, and sold to Talisma in 2006. The company spawned successes like assistly (Alex Bard and Gary Benitt) which sold in 2011 to Salesforce.com.
I work closely with high tech and emerging growth companies, reviewing business plans and market strategies, and facilitating the connections between fast-growing companies and the financial, legal and strategic resources that fuel their growth.
Through SVB, I have close relationships with angel investors, venture capitalists, and private equity firms (many of whom are clients), as well as industry leaders, enabling me to facilitate match-making relationships for growth.
Christian Salaman is an attorney in the Corporate & Securities practice group at Pillsbury Winthrop Shaw Pittman LLP. His practice focuses on the buying, selling and financing of businesses, as well as governance issues, operational matters and strategic relationships.
Life sciences specialty finance professional, venture capital investor, business development and operations executive, scientist, banker and consultant.
Expertise: Life science venture debt and equity financings, life science startup formation, strategy, business development and M&A, startup operations, and financing. Venture fund investment strategy, deal analysis, investment exit strategy identification and execution. Board roles for private companies.
Specialties:Startup formation, exit strategy identification and exit execution, and company financing, with direct experience in venture capital investing (VC equity and venture debt). Life Science business development, M&A and technology commercialization. Board representation. Ph.D. in Molecular Biology.
Nimesh Shah is Chief Business Officer of Fractyl. Nimesh brings with him nearly 20 years of venture capital and Wall Street experience specializing in early-stage or growth oriented medical device companies. Prior to joining Fractyl, Nimesh was a partner of Domain Associates, a leading health care venture capital firm, leading that firm’s efforts in medical devices. Previously, Nimesh served in various roles at venture firm Cutlass Capital and investment bank Alex. Brown (now Deutsche Bank). Nimesh received his B.S. in Biomedical Engineering from the Johns Hopkins University.
Peter Shaw is a Principal in Shaw Management Advisors, Int’l LLC, (SMAI) a San Diego based international advisory firm that provides services for Senior Management, Boards, Venture Capitalists and Entrepreneurs. SMAI specialize in advising its clients in strategic and operational aspects of their business. A number of assignments have included M&A, as well as Corporate restructuring.
Mr. Shaw continues to be active as a business advisor and has recently successfully completed small business M&A assignments. He currently serves on both US based and International Company Boards of Directors
Software and health care technology investor at JMI Equity, a growth-focused private equity firm with more than $3B of committed capital.
Sureel has been part of the JMI team since 2010 and focuses on the healthcare IT sector. He is responsible for sourcing and evaluating investment opportunities as well as providing strategic and operational support to portfolio companies. Prior to joining JMI, Sureel was a business analyst at McKinsey & Company. He also worked in sales operations and business development for DoubleDutch, a mobile software company focused on the events space.
Randy Socol is focusing his practice on the corporate representation of established and emerging growth companies in the technology, biotechnology, media/entertainment, consumer product, clean technology and medical device sectors and the venture capital firms, corporate and strategic investors and acquirors that finance and/or acquire these companies.
In addition to providing strategic and corporate counseling, his practice encompasses venture capital financings, mergers and acquisitions, debt financings, public offerings, equity and compensation matters and corporate governance.
Randy currently splits his time between DLA Piper’s San Diego and Los Angeles offices and is the Co-Chair of the firm’s US Emerging Growth and Venture Capital practice, as well as a founding member of the firm’s Corporate Venture Leadership Group.
I am a Shareholder of Mayer Hoffman McCann P.C. I have been with the Firm since 1999 and have been in public accounting since 1992.
My technical expertise is in providing audit and consulting services to technology and life science companies, both publicly traded and privately held, including many backed by venture capital. I have served as the audit partner on initial public offerings, as well as on innumerable other registration statement filings and 34 act filings. I am also our office’s Attest Practice Leader.
I assist my clients with revenue recognition, purchase accounting, accounting for stock-based compensation, equity and debt instruments, derivatives accounting, and general business consulting enabling clients to make informed decisions on financial reporting matters.
Mr. Bruce D. Steel has been a Managing Director at BioMed Ventures LP since September 2010. Mr. Steel serves as an officer on the executive team of BioMed Realty Trust Inc. Since 2005 until its acquisition in 2008, he was Co-Founder of Rincon Pharmaceuticals, Inc., and served as its Chief Executive Officer. Mr. Steel served as Chief Business Officer of RuiYi Inc. He served as the Head of corporate development at Ambit Biosciences. Prior to Ambit, he directed corporate development at Akesis Pharmaceuticals, a diabetes therapy company founded by Kevin Kinsella (Avalon Ventures). Mr. Steel served as Chairman of Board of Directors of Zosano Pharma Corporation from June 2013 to May 9, 2016 and has been its Director since April 2012. He serves as a Director at AEGEA Medical Inc. He served as Chairman of Board of Directors of Rincon Pharmaceuticals Inc. He served as a Board Observer at TRACON Pharmaceuticals, Inc. since September 22, 2014. He served as a Director of Zosano, Inc. from October 31, 2013 to April 7, 2014. Mr. Steel received his Bachelor of Arts degree from Dartmouth College in 1988, his Masters of Business Administration degree from the Marshall School of Business at the University of Southern California in 1995, and holds the designation of Chartered Financial Analyst.
Lori Steele Contorer is the world’s top expert in election modernization, pioneering the adoption of software as a service and bringing proven state of the art technologies, already proven in other mission–critical industries, to make elections more accessible, affordable, transparent and secure. The transformation has begun, and her visionary leadership in business, innovation and elections led to Ms. Steele Contorer being named in 2013 to Fortune Magazine’s 10 Most Powerful Women Entrepreneurs List, a winner of San Diego Business Journal’s Women Who Mean Business Award and her induction into the Bowling Green State University Dallas Hamilton Entrepreneur’s Hall of Fame. Since founding Everyone Counts she has led successful election administration and voting projects in countries including the United States, Canada, the United Kingdom, Bosnia & Herzegovina, and Australia, serving voters located in over 165 countries, as well as for the transition from vote by mail to secure online voting for the iconic Oscar and Emmy awards. Ms. Steele Contorer previously served as Vice President, Investments at Citigroup, specializing in searching out the most game-changing emerging and state-of-the-art technologies globally, and the companies that would lead industry transformation of those innovative technologies best. Steele Contorer’s election modernization expertise and insights is frequently called on by legislators from around the world, and the media, including Time, the Wall Street Journal, CNN, Fox, MSNBC, Politico and The New York Times.
Bringing 25 years of venture experience to a new opportunity with the great team and my good friends at Cooley!
Experienced entrepreneur, manager, investor, board member and civic leader. As an entrepreneur and manager have built start-up financial services companies and re-energized mature non-profit organizations. Have been a board member for 25 companies, including 2 public companies. Currently Chairman of one private company, director of one private company and board advisor to two others.
Court R. Turner, J.D. joined Avalon Ventures in 2008 as an Advisor and became a Venture Partner in 2010. Mr. Turner is President, CEO and Director of Carolus Therapeutics, COO and Director of Afraxis, and Director of Zacharon Pharmaceuticals, each Avalon VIII portfolio companies. Additionally, Court led Avalon’s investment in RQx Pharmaceuticals as its founding CEO and Chairman; is COO and Director of Sova Pharmaceuticals; and a Board Observer of Cardeas Pharma, each Avalon IX portfolio companies.
Grant Wright has more than 25 years of senior management experience leading external affairs and business development for major American and Canadian corporations and their subsidiaries. With extensive skills in all aspects of communications including media, regulatory, governmental, community outreach and labor relations; he has also led major infrastructure project development, M&A due diligence and implementation management, marketing and brand development efforts and strategic and business plan development for Fortune 500 companies as well as small to mid-level growth ventures. Grant joined (W)right On full-time in 2004. As Managing Partner, Grant provides oversight and senior-level communications and business counsel for the agency’s clients while also overseeing agency management and administration. Grant holds a Bachelor of Science degree in Biology and a Master of Business Administration degree in Marketing and Finance. Professionally, he has been involved in corporate and not-for-profit association boards of directors. During his free time, Grant enjoys scuba diving, hiking and being a mentor for university students entering their professional career. He is also a commercial pilot licensed in both Canada and the U.S. and is the founding board chairman of the now 5,000+ member Southern California Aviation Association that has provided more than $300,000 in student scholarship grants in the past five years alone.
Wednesday, September 7 – Thursday, September 8, 2016 This event registration for pre-approved VC invitees only If you are a venture fund manager and would like to be included please contact SDVG President Mike Krenn at firstname.lastname@example.org. This[...]
Venture Summit is the largest annual gathering of VCs in Southern California! This year at the Hilton San Diego Bayfront 600+ people will gather to meet 40+ Cool Companies, and hear speakers from top tier venture[...]